Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 06:55:44 UTC
Update Date2021-09-26 23:01:08 UTC
HMDB IDHMDB0249963
Secondary Accession NumbersNone
Metabolite Identification
Common Name3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester
DescriptionN-[(2H-1,3-benzodioxol-5-yl)methyl]-2-{1-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]-4-(methoxycarbonyl)piperazin-2-yl}ethanimidic acid belongs to the class of organic compounds known as n-arylpiperazines. These are organic compounds containing a piperazine ring where the nitrogen ring atom carries an aryl group. Based on a literature review very few articles have been published on N-[(2H-1,3-benzodioxol-5-yl)methyl]-2-{1-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]-4-(methoxycarbonyl)piperazin-2-yl}ethanimidic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). 3-{[(benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
N-[(2H-1,3-Benzodioxol-5-yl)methyl]-2-{1-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]-4-(methoxycarbonyl)piperazin-2-yl}ethanimidateGenerator
3-{[(benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylate methyl esterGenerator
Chemical FormulaC23H25N7O5
Average Molecular Weight479.497
Monoisotopic Molecular Weight479.191716933
IUPAC Namemethyl 3-({[(2H-1,3-benzodioxol-5-yl)methyl]carbamoyl}methyl)-4-[2-(1H-imidazol-1-yl)pyrimidin-4-yl]piperazine-1-carboxylate
Traditional Namemethyl 3-{[(2H-1,3-benzodioxol-5-ylmethyl)carbamoyl]methyl}-4-[2-(imidazol-1-yl)pyrimidin-4-yl]piperazine-1-carboxylate
CAS Registry NumberNot Available
SMILES
COC(=O)N1CCN(C(CC(=O)NCC2=CC3=C(OCO3)C=C2)C1)C1=NC(=NC=C1)N1C=CN=C1
InChI Identifier
InChI=1S/C23H25N7O5/c1-33-23(32)28-8-9-30(20-4-5-25-22(27-20)29-7-6-24-14-29)17(13-28)11-21(31)26-12-16-2-3-18-19(10-16)35-15-34-18/h2-7,10,14,17H,8-9,11-13,15H2,1H3,(H,26,31)
InChI KeyNVYMEDQKBQMAKF-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as n-arylpiperazines. These are organic compounds containing a piperazine ring where the nitrogen ring atom carries an aryl group.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassDiazinanes
Sub ClassPiperazines
Direct ParentN-arylpiperazines
Alternative Parents
Substituents
  • N-arylpiperazine
  • Beta amino acid or derivatives
  • Benzodioxole
  • Piperazine-1-carboxylic acid
  • Imidazolyl carboxylic acid derivative
  • Dialkylarylamine
  • Aminopyrimidine
  • N-substituted imidazole
  • Imidolactam
  • Benzenoid
  • Pyrimidine
  • Methylcarbamate
  • Azole
  • Imidazole
  • Heteroaromatic compound
  • Carbamic acid ester
  • Carboxamide group
  • Secondary carboxylic acid amide
  • Azacycle
  • Oxacycle
  • Carboxylic acid derivative
  • Acetal
  • Organonitrogen compound
  • Hydrocarbon derivative
  • Carbonyl group
  • Organic oxide
  • Organopnictogen compound
  • Organic oxygen compound
  • Organooxygen compound
  • Organic nitrogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP1ALOGPS
logP1.43ChemAxon
logS-2.7ALOGPS
pKa (Strongest Acidic)14.84ChemAxon
pKa (Strongest Basic)6.16ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count8ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area123.94 ŲChemAxon
Rotatable Bond Count7ChemAxon
Refractivity134.86 m³·mol⁻¹ChemAxon
Polarizability49.34 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+203.85630932474
DeepCCS[M-H]-201.4630932474
DeepCCS[M-2H]-234.34530932474
DeepCCS[M+Na]+209.76830932474

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl esterCOC(=O)N1CCN(C(CC(=O)NCC2=CC3=C(OCO3)C=C2)C1)C1=NC(=NC=C1)N1C=CN=C15122.8Standard polar33892256
3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl esterCOC(=O)N1CCN(C(CC(=O)NCC2=CC3=C(OCO3)C=C2)C1)C1=NC(=NC=C1)N1C=CN=C14018.4Standard non polar33892256
3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl esterCOC(=O)N1CCN(C(CC(=O)NCC2=CC3=C(OCO3)C=C2)C1)C1=NC(=NC=C1)N1C=CN=C14451.4Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester,1TMS,isomer #1COC(=O)N1CCN(C2=CC=NC(N3C=CN=C3)=N2)C(CC(=O)N(CC2=CC=C3OCOC3=C2)[Si](C)(C)C)C14205.0Semi standard non polar33892256
3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester,1TMS,isomer #1COC(=O)N1CCN(C2=CC=NC(N3C=CN=C3)=N2)C(CC(=O)N(CC2=CC=C3OCOC3=C2)[Si](C)(C)C)C14281.5Standard non polar33892256
3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester,1TMS,isomer #1COC(=O)N1CCN(C2=CC=NC(N3C=CN=C3)=N2)C(CC(=O)N(CC2=CC=C3OCOC3=C2)[Si](C)(C)C)C16144.3Standard polar33892256
3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester,1TBDMS,isomer #1COC(=O)N1CCN(C2=CC=NC(N3C=CN=C3)=N2)C(CC(=O)N(CC2=CC=C3OCOC3=C2)[Si](C)(C)C(C)(C)C)C14393.6Semi standard non polar33892256
3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester,1TBDMS,isomer #1COC(=O)N1CCN(C2=CC=NC(N3C=CN=C3)=N2)C(CC(=O)N(CC2=CC=C3OCOC3=C2)[Si](C)(C)C(C)(C)C)C14474.8Standard non polar33892256
3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester,1TBDMS,isomer #1COC(=O)N1CCN(C2=CC=NC(N3C=CN=C3)=N2)C(CC(=O)N(CC2=CC=C3OCOC3=C2)[Si](C)(C)C(C)(C)C)C16123.3Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester GC-MS (Non-derivatized) - 70eV, Positivesplash10-000i-2946200000-e1895bcbf453c9b09ac52021-09-24Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester 10V, Negative-QTOFsplash10-004j-0000900000-7bc3d5fa5f64f2aa0d882021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester 20V, Negative-QTOFsplash10-01t9-0141900000-1ab01e2f7b2e295e3c772021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester 40V, Negative-QTOFsplash10-00kf-3092100000-a135df33e8c89dbdef4b2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester 10V, Positive-QTOFsplash10-001i-0000900000-33baf7f793b6aa890f5b2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester 20V, Positive-QTOFsplash10-001j-0201900000-8dc94ead6cda336680422021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 3-{[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-methyl}-4-(2-imidazol-1-yl-pyrimidin-4-yl)-piperazine-1-carboxylic acid methyl ester 40V, Positive-QTOFsplash10-000i-5922200000-f7ef105398d92f2251b42021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID8565811
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]